ALFA Finder| Value | ₹0.85 Cr |
|---|---|
| Execution period | Completion expected by 31 January 2027 |
BSE filing, NSE: KOVAI. Summary written from the filing by ALFA Finder's alert engine.
Kovai Medical Center and Hospital Ltd: key numbers
- Share price
- ₹6,125.00
- Market cap
- ₹6,702 Cr
- Revenue (annual)
- ₹1,586 Cr
- Net profit (annual)
- ₹244.5 Cr
- P/E (TTM)
- 26.5×Sector 54.4×
- Promoter holding
- 56.53%+0.01% QoQ
- FII holding
- 1.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kovai Medical Center and Hospital Ltd
All →Kovai Medical Center and Hospital Q2 FY27 Results: Net Profit ₹77 Cr, Up 30.7% YoY
Kovai Medical Center and Hospital Ltd reported revenue from operations of ₹472.6 Cr (+20.8% YoY) and net profit of ₹77 Cr (+30.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹77 Cr · +30.7% YoY
Kovai Medical Center and Hospital Legal & Regulatory
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
- Value
- ₹2.11 Cr
Kovai Medical Center and Hospital Board Meeting Date
Kovai Medical Center intimated BSE that its Board will meet on 11 Nov 2026 to approve unaudited results for the quarter ended 30 Sep 2026. No financial figures or other decisions are disclosed yet.
Kovai Medical Center and Hospital Other Announcement
Kovai Medical Center & Hospital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a routine periodic regulatory disclosure with no new transaction.
Kovai Medical Center and Hospital Promoter Buying: ₹0.19 Cr
Promoter Pavai Property Developers acquired 316 shares of Kovai Medical Center via open market purchase for ₹0.19 Crore. This increases their holding slightly.
- Value
- ₹0.19 Cr
Kovai Medical Center and Hospital Promoter Buying: ₹0.31 Cr
Promoter entity Pavai Property Developers Private Limited purchased 500 equity shares of Kovai Medical Center & Hospital Ltd via market acquisition.
- Value
- ₹0.31 Cr
Other merger & restructuring announcements
All →Adani Enterprises Merger & Restructuring Worth ₹0.94 Cr
Adani Enterprises reported incorporation of Adani Rovuma Chemicals Limited in UAE on November 10, 2026, via Adani Global Limited. Cash consideration of Rs. 0.94 Crore was stated.
- Value
- ₹0.94 Cr
Adani Enterprises Merger & Restructuring
Adani Enterprises' subsidiary Adani Global incorporated Adani Rovuma Chemicals Limited in UAE on November 10, 2026. It is a step-down subsidiary with USD 100,000 paid-up capital.
Gita Renewable Energy Merger & Restructuring
Gita Renewable Energy's board approved becoming a 5% partner in Penthouse Properties LLP, a non-related entity. The company will contribute 22,05,022 Manaksia Coated Metals shares as capital, about 2.08% of that company.
Tulsyan NEC Merger & Restructuring Worth ₹3.81 Cr
Tulsyan NEC completed the sale of its 12,700 sq. m leasehold industrial land in Goa to Mangal Iron Private Limited for ₹3.81 Crore. The buyer is a third party, not a related party, and the full consideration has been received.
- Value
- ₹3.81 Cr
Dabur India Merger & Restructuring
Dabur India disclosed that Atlanta Body and Health Products, a step-down subsidiary, was liquidated and closed effective 10 November 2026. No consideration or financial amount is stated.
Bondada Engineering Merger & Restructuring Worth ₹0.05 Cr
Bondada Engineering incorporated Bondada International FZ-LLC in RAKEZ, UAE, as a wholly owned subsidiary. The subscription amounts to AED 20,000, about Rs.0.05 Crore.
- Value
- ₹0.05 Cr